Healthcare Services Business Valuation: What Home Care and Medical Businesses Sell For
"Healthcare services" covers businesses that trade at wildly different multiples depending on certification and payer mix, and lumping them together is the fastest way to misprice a deal. Non-medical, private-duty personal care agencies — no Medicare certification required — clear roughly 3x-5x EBITDA, or about 2x-3.5x SDE for smaller owner-run shops. Medicare-certified skilled home health agencies with $5M-$25M in revenue and multiple branches trade at 6x-9x. Scaled multi-state platforms with a diversified payer mix and a strong CMS star rating reach 9x-12x or more, with hospice — often called the crown jewel of the category — commanding 9x-12.5x on its own. Broader healthcare services EV/EBITDA multiples have actually moderated to roughly 11.5x industry-wide, down from about 14.5x in 2024, so even at the top of the market pricing has cooled from its recent peak.
Typical Valuation Range
| Segment | Typical multiple | Profile |
|---|---|---|
| Non-medical private-duty care | 3x - 5x EBITDA (2x-3.5x SDE, owner-run) | No Medicare certification, private-pay or long-term-care insurance |
| Medicare-certified skilled home health, $5M-$25M revenue | 6x - 9x EBITDA | Multi-branch, clean survey history, established referral base |
| Scaled multi-state platform | 9x - 12x+ EBITDA | Diversified payer mix, 4.5-5 star CMS rating |
| Hospice | 9x - 12.5x EBITDA | Certified hospice programs, strong census and referral network |
Certification Status Does More Work Than Revenue Size
A $3M private-duty agency and a $3M Medicare-certified skilled agency can look nearly identical on a top-line P&L and still be worth completely different multiples, because certification changes everything about the revenue's reliability and regulatory burden. Medicare certification opens access to a much larger, more stable payer, but it also brings survey requirements, billing compliance obligations, and exposure to CMS rate changes that a private-pay agency simply doesn't carry. Buyers need to identify which category a target actually falls into before anchoring on any multiple pulled from a general "home care" search.
Corporate Practice of Medicine and MSO Structures
Many states restrict who can legally own a medical or clinical practice — corporate practice of medicine (CPOM) laws generally require that a licensed physician or professional corporation, not an outside investor, hold the clinical license. Non-clinical buyers get around this with a management services organization (MSO) structure: the buyer's entity owns the equipment, staff, billing systems, and real estate, and contracts with a physician-owned professional corporation for the clinical services themselves. Get healthcare-specific legal counsel involved before signing a letter of intent, since a poorly structured deal can trigger Stark Law, Anti-Kickback Statute, or state licensing problems that are far more expensive to unwind after closing than to structure correctly up front.
What Pushes the Multiple Up
- Diversified payer mix: no single commercial payer or government program representing an outsized share of revenue
- Clean compliance and survey history: no recent CMS deficiencies, exclusions, or billing audit findings
- Multiple branches or service lines that demonstrate the model works without the founder personally running every location
- Strong, documented referral relationships with hospitals and physician groups that are tied to the business rather than one individual provider
- Private-pay or cash-pay revenue component that isn't subject to government reimbursement rate changes
What Pulls the Multiple Down
- Heavy concentration in one payer, especially a single commercial insurance contract or Medicaid managed-care plan
- Recent survey deficiencies or an open compliance investigation
- Revenue tied to one or two referral sources with no diversification
- Owner is the sole licensed provider with no succession or credentialed staff depth
Deal Structure and Financing
SBA financing is available for healthcare service acquisitions below roughly $5M in enterprise value, though lenders will underwrite payer-mix and compliance risk more heavily than trailing EBITDA alone. Larger deals, particularly those involving PE-backed platforms, typically use a cash-plus-earnout structure where a portion of price is held back against continued census levels, payer contract retention, or survey outcomes over the first 12-24 months — protecting the buyer from exactly the risks that don't show up in a clean trailing P&L.
Worked Example: Stress-Testing a Payer-Concentrated Agency
A Medicare-certified home health agency reports $620,000 in EBITDA, with Medicare representing 55% of revenue, a single regional Medicaid managed-care plan at 25%, and the remainder private-pay. At a market multiple of 7x for its size and certification tier, the agency prices at $4.34M. Before accepting that number, the buyer runs a stress test: what happens if the Medicaid managed-care plan — which has flagged rate renegotiations across its provider network — cuts reimbursement by 12%? That payer's revenue contribution drops proportionally, and because most of the agency's cost base (nursing staff, compliance, scheduling) doesn't shrink with it, EBITDA falls to roughly $548,000, a 12% hit against only a 25%-of-revenue payer. Repricing at the same 7x multiple against the stressed EBITDA yields $3.84M rather than $4.34M — a $500,000 gap the buyer can either negotiate into the price or structure as a holdback tied to the Medicaid contract surviving its renewal. Run both the trailing and stressed EBITDA figures through the AcquireCalc calculator before finalizing an offer.
Frequently Asked Questions
Why is the multiple range so much wider than most Main Street categories? Because Medicare certification status alone can separate two agencies with similar revenue by several turns of EBITDA. A non-medical private-duty agency with no certification requirements trades at 3x-5x EBITDA, while a Medicare-certified skilled home health agency with a clean survey history and multiple branches trades at 6x-9x, and a scaled multi-state platform with a 4.5-5 star CMS rating can reach 9x-12x or higher. The underlying services can look similar to an outsider, but the regulatory and reimbursement profile is completely different.
Does a non-physician buyer need to worry about corporate practice of medicine laws? Yes, in many states. Corporate practice of medicine (CPOM) laws prohibit non-physicians from owning certain licensed practices outright, which is why buyers structure these deals through a management services organization that owns the non-clinical assets while a physician-owned professional corporation holds the clinical license. This needs healthcare-specific legal counsel before signing an LOI, not after.
How much does a single payer renegotiating rates affect the price? A lot, and it's one of the most underestimated risks in this category. If a payer representing 40-60% of revenue cuts reimbursement rates, the hit flows almost straight through to EBITDA since most of the underlying cost structure (staffing, compliance, overhead) doesn't shrink proportionally. Buyers should model at least one payer-cut scenario before accepting a multiple based on trailing, unstressed EBITDA.
Related
- Accounting / tax practice — comparable licensed-professional practice model
- Professional services — B2B relationship-based services comparison
- All industry multiples